Saturday, February 21, 2026
21.7 C
Bengaluru

Pharma CEO Roundtable on 27th October 2021

Engaging Doctors – Physical, Digital & Hybrid: Translating Strategy Into Action

Keynote Address: Rajaram Narayanan, Managing Director, Sanofi India

Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Panel Members:

Digital will NOT make the pharma sales job redundant. Anything else you’ve heard to the contrary – is a MYTH. In fact, digital technology, digital platforms, and digital tools are an enabler for any Pharma salesperson to execute with sharper impact and reduce wastage.

How will this happen? Join us on the 27th of October as we bring together veterans of the industry and discuss what it truly means to go digital, understand the customer journey, identify the gaps, and leverage content via the right channels.

Highlights of the Pharma CEO Roundtable 2021

  • Mapping the customer journey
  • Identifying and filling the need-gaps of doctors
  • Content curation: What is engaging and why does it matter?
  • The omnichannel approach
  • The Sanofi experience

So, cast your inhibitions and fears away – and jump on the digital bandwagon. Pharma professionals can sign up here to receive the link to view the Pharma CEO Roundtable 2021.

Hot this week

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

Why the World Still Doesn’t Celebrate Antibiotic Breakthroughs llike Zaynich

When a new cancer drug shows promise, it trends...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Topics

India’s Pharma Renaissance: Private Equity at the Helm

Indian pharmaceuticals have long been known as the “pharmacy...

The ₹5 Snack SKU: A Silent Indian Metabolic Crisis

Executive Summary — The Paradox of Scale In the annals...

Sleep Apnea: Apnimed Pill to Replace CPAP Machine?

In India, where urban sleep debt is rising, obesity...

From Overuse to Overreaction: Recalibrating India’s C-Section Debate

India’s caesarean section debate is drifting toward polarisation. On one...

Sanofi’s Decision not to Renew Paul Hudson as CEO Marks a Structural Shift

In big pharma, leadership changes are rarely impulsive. They...

THE ENCUBE ETHICALS PLAYBOOK: FROM GOA WORKSHOP TO $2BN+ GLOBAL DEAL

How a niche Indian topicals manufacturer outgrew its CDMO...

Indian Pharma: Are Regulatory Gaps From Generics Following Biosimilars?

Transparency, Trust, and the Problem of “Invisible Evidence” in...
spot_img

Related Articles

spot_imgspot_img